PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksReabold Resources Regulatory News (RBD)

Share Price Information for Reabold Resources (RBD)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.07
Bid: 0.065
Ask: 0.075
Change: 0.00 (0.00%)
Spread: 0.01 (15.385%)
Open: 0.07
High: 0.07
Low: 0.07
Prev. Close: 0.07
RBD Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Formation of new division

5 Dec 2007 07:01

Adventis Group PLC05 December 2007 For release 7.00am 5th December 2007 Adventis Group plc (ATG/L) "Formation of New Market-Leading Healthcare Services Provider - Adventis Health Limited" Adventis Group plc ("Adventis" or the "Company"), the AIM-quoted full servicemultimedia marketing and advertising agency, announces that it has recentlyconsolidated its three healthcare creative and medical education agencies, whichformed the Adventis Healthcare services division, namely Affiniti Advertising,Roundhouse HealthAd and LeapFrog, into a new trading entity which will bebranded Adventis Health Limited ("Adventis Health"). Adventis Health will be run by three directors, namely Stuart Tennant, TimSchofield and Kevin McGetrick. All three have extensive healthcare andmanagement experience. This consolidation of Adventis Group's strength in the healthcare sector followson from the former division's earlier move into centralised premises inBeaconsfield, near to the M25 and M40, in August 2007 in addition to theCompany's existing offices in Hertford and Central London. Adventis Health, whose clients include, GSK, Pfizer, MSD, Roche, Novartis,Boehringer Ingelheim, Allergan, Baxter and Merck Serono, provides a range ofhighly skilled advertising and marketing services as well as medical education &PR programmes to the healthcare industry, targeted at both healthcareprofessionals and patients, in order to improve clients' sales and brandawareness. The Company anticipates that the formation of Adventis Health will create one ofthe industry's top five pharmaceutical industry service providers with aformidable, award-winning team of over 60 employees. The enlarged Healthcareservices operations will have the capability to provide a complete range ofintegrated marketing services, from medical education, to advertising, to newmedia. It will also provide the opportunity for an increased level ofcross-selling and the ability to provide multinational clients with a greaterlocal understanding of target markets. Charles Phillpot, Chief Executive of Adventis Group plc, commented: "The creation of this new platform servicing the healthcare sector is afantastic opportunity to leverage to the full our expertise in this arena. Wewill now be one of the few companies in the industry to offer a full servicemarketing capability and the ability to handle larger and more complex campaignsfor clients." -ENDS- Enquiries: Adventis Group PlcCharles Phillpot, CEO Tel: 020 7034 4750Peter Linnell, Finance Director Tel: 020 7034 4795 Adventis Financial PRChris Steele Tel: 020 7034 4759Tarquin Edwards Tel: 020 7034 4758 Editor's Note: Adventis Group plc provides a complete range of communications services,including corporate identity programmes, advertising campaigns, media andplanning and buying, literature, public relations, packaging, exhibitions,research and planning, interiors signage and digital media. The group employsc.150 staff in London and the southeast. Adventis has three divisions focusing on providing a range of services to theproperty, healthcare and financial sectors. Adventis Group was admitted to AIMin 2004. www.adventis.co.uk This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
9th May 20247:00 amRNSChange of Broker
2nd May 20247:00 amRNSHoA Signed between Gunvor and LNEnergy
27th Feb 20247:00 amRNSOperational and Corporate Update
20th Feb 20247:00 amRNSInvestor Presentation
18th Jan 20247:00 amRNSNotification of final tranche of Shell payment
11th Jan 20247:00 amRNSTransaction in Own Shares
10th Jan 202411:47 amRNSResult of Requisitioned General Meeting
10th Jan 20247:00 amRNSTransaction in Own Shares
9th Jan 20247:00 amRNSTransaction in Own Shares
8th Jan 20247:00 amRNSTransaction in Own Shares
5th Jan 20247:00 amRNSTransaction in Own Shares
4th Jan 20243:40 pmRNSUpdate re Requisitioned General Meeting
4th Jan 20247:00 amRNSTransaction in Own Shares
3rd Jan 20247:00 amRNSTransaction in Own Shares
2nd Jan 20247:00 amRNSTransaction in Own Shares
29th Dec 20237:00 amRNSGlass Lewis Recommendation
29th Dec 20237:00 amRNSTransaction in Own Shares
28th Dec 20237:00 amRNSUpdate re Requisitioned General Meeting
28th Dec 20237:00 amRNSTransaction in Own Shares
27th Dec 202311:03 amRNSTransaction in Own Shares
22nd Dec 20237:00 amRNSISS Supports the Board of Reabold
22nd Dec 20237:00 amRNSTransaction in Own Shares
21st Dec 20237:07 amRNSTransaction in Own Shares
20th Dec 20237:00 amRNSTransaction in Own Shares
20th Dec 20237:00 amRNSEnvironmental Impact Study Filed for Colle Santo
19th Dec 20237:00 amRNSTransaction in Own Shares
18th Dec 20237:00 amRNSTransaction in Own Shares
15th Dec 20237:00 amRNSTransaction in Own Shares
14th Dec 20237:00 amRNSTransaction in Own Shares
13th Dec 20237:01 amRNSRecommencement of Share Buyback Programme
13th Dec 20237:00 amRNSPublication of Circular
11th Dec 20237:00 amRNSFurther Investment into LNEnergy
7th Dec 20233:42 pmRNSHolding(s) in Company
5th Dec 20237:00 amRNS£5.2 million received for the sale of Corallian
1st Dec 20237:00 amRNSItalian Government Decree on Energy Sector
22nd Nov 20235:10 pmRNSRequisition of General Meeting
17th Nov 20237:00 amRNSFurther Investment into LNEnergy
14th Nov 20237:00 amRNSPurported Requisition of General Meeting
8th Nov 202310:50 amRNSRequisition of General Meeting
3rd Nov 20234:10 pmRNSResponse to Media Reporting
3rd Nov 20234:02 pmRNSHolding(s) in Company
28th Sep 20237:00 amRNSUnaudited Interim Results
27th Sep 20237:00 amRNSApproval for EA Permit at West Newton
12th Sep 20237:00 amRNSFurther Investment into LNEnergy
5th Sep 20237:00 amRNSColle Santo Project Enters Operational Phase
7th Aug 20237:00 amRNSUpdate on LNEnergy and the Colle Santo gas field
24th Jul 202312:24 pmRNSHolding(s) in Company
21st Jul 20237:00 amRNSTransaction in Own Shares
19th Jul 20237:00 amRNSTransaction in Own Shares
18th Jul 20237:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.